Form 4 for PG Procter & Gamble
Accepted 2025-10-02 00:00:00 ET · period of report 2025-10-01 · accession 0000080424-25-000192 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-02 | 2025-10-01 | PG | Jejurikar Shailesh | COO | A - Grant | $0.00 | +22.8K | 50.9K | +81% | $0 |
| D | 2025-10-02 | 2025-10-01 | PG | Jejurikar Shailesh | COO | A - Grant | $0.00 | +105.6K | 105.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-01 | A | A | 22,849 | $0.00 | 50,885.38 | D | — | — | (F1) Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-10-01 | A | A | 105,581 | $0.00 | 105,581 | D | $153.18 · 2028-09-29 to 2035-10-01 | 105,581 Common Stock |